Subscribe To
Qualcomm: a magic formula dividend deal
This is a cheap stock being mispriced in a cyclical downturn. Qualcomm's return on invested capital at ...
July 5, 2023, 11:57 am
Challenger energy's uruguay offshore award formally approved by regulator
Challenger Energy Group PLC (AIM:CEG, OTC:BSHPF), the Caribbean and Americas-focused oil and gas company, has announced that the award of the AREA OFF...
July 3, 2023, 3:48 am
: madrigal pharmaceuticals’ stock up 5% as company starts rolling submission for fda approval of nash treatment
Madrigal Pharmaceuticals Inc.’s stock MDGL rose 5% Friday after the company said it has started a rolling submission of a New Drug Application to th...
June 30, 2023, 4:28 pm
Madrigal pharmaceuticals' stock up 5% as company starts rolling submission for fda approval of nash treatment
Madrigal Pharmaceuticals Inc.'s stock MDGL, +5.00% rose 5% Friday after the company said it has started a rolling submission of a New Drug Application...
June 30, 2023, 12:28 pm
Constellation brands reports first quarter fiscal 2024 financial results
VICTOR, N.Y., June 30, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage al...
June 30, 2023, 11:30 am
Eurozone cpi slowed to 5.5% yoy in jun, cpi core rose to 5.4% yoy
Eurozone CPI slowed from 6.1% yoy to 5.5% yoy in June, below expectation of 5.6% yoy. CPI core rose from 5.3% yoy to 5.4% yoy, matched expectations. L...
June 30, 2023, 9:08 am
Constellation brands 1q financial results beat estimates on higher beer sales
Constellation Brands (NYSE:STZ), Inc announced first quarter fiscal 2024 adjusted earnings of $2.91 per share, up from $2.66 per share a year ago and ...
June 30, 2023, 8:43 am
Medicinova announces presentation of results from the phase 2b trial of mn-166 (ibudilast) in alcohol use disorder at the 46th annual research society on alcohol (rsa) scientific meeting
LA JOLLA, Calif., June 29, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
June 29, 2023, 10:00 am
New ai chip export rules put semiconductor firms in spotlight
The new rules will make it harder for companies like NVIDIA (NVDA), Advanced Micro (AMD), Intel (INTC) and Qua...
June 29, 2023, 9:54 am
Why qualcomm stock was trading down earlier wednesday
The U.S. is considering further export restrictions on advanced computing chips. The news represents another potential headwind for Qu...
June 28, 2023, 1:41 pm
Idcc or qcom: which is the better value stock right now?
Investors interested in stocks from the Wireless Equipment sector have probably already heard of InterDigital (IDCC) and Qu...
June 28, 2023, 12:51 pm
Eton pharmaceuticals receives complete response letter (crl) for dehydrated alcohol injection
DEER PARK, Ill., June 28, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developi...
June 28, 2023, 10:50 am
Qualcomm: attractive value despite the cyclical downturn
Qualcomm has reported recent quarter financial results with significant declines as expected. The compa...
June 27, 2023, 2:59 am
Renault ceo says free float of future electric unit will be less than 10%
A sizeable chunk of Renault's planned electric vehicle spinoff could remain in free float on the stock market, its CEO said in an interview published ...
June 27, 2023, 2:57 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am